A phantom study for in-vivo dosimetry of high dose rate brachytherapy applicators

Muhammad Asghar Gadhi, Saeed Ahmad Buzdar, Muhammad Arshad, Muhammad Akram, Farooq Aziz, Aziz-Ur Rehman, Shahab Fatmi


Purpose: The aim of the current investigation was to calibrate the diode in-vivo dosimetry (IVD) system for high-dose-rate (HDR) brachytherapy and to design a phantom study for in-vivo dosimetry of HDR brachytherapy applicators.

Methods: Gamma Med Plus with Abacus 3.1 treatment planning system (TPS), and diode dosimetry system has been used in this study. Calibration and different correction factors of diode have been measured in water phantom. Treatment simulation, planning of different applicators for esophagus, rectum/vagina and cervix (fletcher & ring), dose delivery and finally in-vivo verification at prescription point using diode in water phantom has been performed.

Results: The mean calibration factor for diode for Ir-192 HDR source is 1.256 (N=15) with σ ± 0.0015. The overall average percentage difference between TPS dose and diode dose was 1.87% (σ ± 2.64) for all measurements, 1.86% (σ ± 2.73) for esophagus, 1.86% (σ± 2.94) for rectum/vagina and 1.67% (σ ±2.81) for fletcher and 2.07% (σ ± 2.26) for ring applicators, respectively. These results advocate that the dose calculated by TPS and dose measured using diode for the various clinical situations deliberated here are in good agreement (~2%) at the points of clinical importance.

Conclusion: The in-vivo phantom dosimetry study gives both a confidence that the treatments are being delivered as prescribed and enhance the reliability of the HDR brachytherapy treatment. This may be used for acceptance testing/commissioning of new treatment planning system and to validate the new brachytherapy techniques in the clinics. 


Brachytherapy, In-vivo dosimetry, Phantom, Ir-192, HDR

Full Text:



Talluri AK, Yarrama AR, Ahamed S, et al. Dose variation due to change in planned position for patients with carcinoma of the cervix undergoing high-dose-rate brachytherapy- 2D dose analysis. Int J Cancer Ther Oncol 2015; 3(1):030121.

Halperin EC, Brady LW, Wazer DE, Perez CA. Perez & Brady’s principles and practice of radiation oncology, Chapter 25. 6th ed: Lippincott Williams & Wilkins; 2013.

Tanderup K, Hellebust TP, Lang S, et al. Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer. Radiother Oncol. 2008;89(2):156-63.

Mayles W. The Glasgow Incident—A physicist's reflections. Clin Oncol. 2007;19(1):4-7.

Williams MV. Radiotherapy near misses, incidents and errors: radiotherapy incident at Glasgow. Clin Oncol. 2007;19(1):1-3.

Lopez PO, Cosset JM, Dunscombe P, et al. Preventing accidental exposures from new external beam radiation therapy technologies. Ann ICRP. 2009;39(4):1-86.

Derreumaux S, Etard C, Huet C, et al. Lessons from recent accidents in radiation therapy in France. Radiat Prot Dosimetry. 2008;131(1):130-5.

Thomadsen B, Lin S-W, Laemmrich P, et al. Analysis of treatment delivery errors in brachytherapy using formal risk analysis techniques. Int J Radiat Oncol Biol Phys. 2003;57(5):1492-508.

Ortiz P. Lessons learned from accidental exposures in radiotherapy. IAEA Safety Reports Series. 2000;17:59-61.

Lopez PO, Andreo P, Cosset JM, et al. Prevention of accidental exposures to patients undergoing radiation therapy. ICRP Publication 86. Ann ICRP. 2000.

Valentin J. Prevention of high-dose-rate brachytherapy accidents. ICRP Publication 97. Ann ICRP. 2004;35(2):1-51.

World Health Organization. Radiotherapy risk profile. 2008.

IAEA. Development of procedures for in vivo dosimetry in radiotherapy, IAEA Human Health Report No. 8. Vienna, Austria: International Atomic Energy Agency. 2013.

Yorke E, Alecu R, Ding L, et al. Diode in vivo dosimetry for patients receiving external beam radiation therapy. AAPM Report of Task Group 62. 2005.

Huyskens D, Bogaerts R, Verstraete J, et al. Practical guidelines for the implementation of in vivo dosimetry with diodes in external radiotherapy with photon beams (entrance dose). ESTRO Booklet. 2001;5:13-28.

Mayo CS. A method for checking high dose rate treatment times for vaginal applicators. J Appl Clin Med Phys. 2001;2(4):184-90.

Gil’ad NC, Amols HI, Zaider M. An independent dose-to-point calculation program for the verification of high-dose-rate brachytherapy treatment planning. Int J Radiat Oncol Biol Phys. 2000;48(4):1251-8.

Ezzell GA. A manual algorithm for computing dwell times for two-catheter endobronchial treatments using HDR brachytherapy. Med Phys. 2000;27(5):1030-3.

Kumar R, Sharma SD, Vijaykumar C, et al. A dose verification method for high-dose-rate brachytherapy treatment plans. J Cancer Res Ther. 2008;4(4):173-7.

Buzdar SA, Gadhi MA, Rao MA, et al. Verification of computerized treatment planning for HDR 192Ir brachytherapy for gynecological cancer. J Pak Med Assoc.2009;59(2):113-5.

Gadhi MA, Fatmi S, Shakil M, et al. A method for verification of treatment times for high-dose-rate intraluminal brachytherapy treatment. Int J Cancer Ther Oncol. 2016;4(2):423.

Adeyemi A, Lord J. An audit of radiotherapy patient doses measured with in vivo semiconductor detectors. Br J Radiol. 1997;70(832):399-408.

Gadhi MA, Fatmi S, Chughtai GM, et al. Verification of absorbed dose using diodes in cobalt-60 radiation therapy. Australas Phys Eng Sci in Med. 2016;39(1):211-9.

Devic S, Seuntjens J, Abdel-Rahman W, et al. Accurate skin dose measurements using radiochromic film in clinical applications. Med Phys. 2006;33(4):1116-24.

Alecu R, Alecu M. In-vivo rectal dose measurements with diodes to avoid misadministrations during intracavitary high dose rate brachytherapy for carcinoma of the cervix. Med Phys. 1999;26(5):768-70.

Allahverdi M, Sarkhosh M, Aghili M, et al. Evaluation of treatment planning system of brachytherapy according to dose to the rectum delivered. Radiat Prot Dosimetry. 2012;150(3):312-5.

Oyekunle EO, Obed RI, Akinlade BI, et al. Comparison of doses to the rectum derived from treatment planning system with in-vivo dose values in vaginal vault brachytherapy using cylinder applicators. J Contemp Brachytherapy. 2015;7(6):485-91.

Talluri AK, Yarrama A, Ahamed S, et al. Body mass index versus bladder and rectal doses using 2D planning for patients with carcinoma of the cervix undergoing HDR brachytherapy. Int J Cancer Ther Oncol. 2016;4(2):422.

Gadhi MA, Buzdar SA, Fatmi S. In-vivo dosimetry with diode for the treatment of pelvic malignancies. Aust Oncol Reports. 2016;1(1):01-4.

Gadhi MA, Buzdar S, Afzal M, et al. Calibration of iridium-192 source by ionization chamber for high dose rate brachytherapy. Int J Radiat Res. 2013;11(3):189-93.

Tanderup K, Christensen JJ, Granfeldt J, et al. Geometric stability of intracavitary pulsed dose rate brachytherapy monitored by in vivo rectal dosimetry. Radiother Oncol. 2006;79(1):87-93.

Saarnak AE, Boersma M, van Bunningen BN, et al. Inter-observer variation in delineation of bladder and rectum contours for brachytherapy of cervical cancer. Radiothe Oncol. 2000;56(1):37-42.

DOI: http://dx.doi.org/10.14319/ijcto.44.2

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.


International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)

© International Journal of Cancer Therapy and Oncology (IJCTO)

To make sure that you can receive messages from us, please add the 'ijcto.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.


Number of visits since October, 2013